Post-exercise Insulin Reductions in Type 1 Diabetes

Northumbria University

Status: Completed

Conditions: Type 1 Diabetes

Treatments: Other: Reducing post-exercise rapid-acting insulin (insulin lispro or aspart) dose

Study type: Interventional

Funder types: Other

Identifiers

NCT01531855

west-walker1

Details and patient eligibility

About

The investigators hypothesise that reducing rapid-acting insulin dose after exercise will help prevent Type 1 diabetes individuals experiencing hypoglycaemia.

Enrollment: 13 patients

Sex: Male

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• T1DM,
• Male,
• basal-bolus regimen (insulin glargine / detemir with insulin lispro / aspart),
• HbA1c < 9.9%,
• aged 18-50.

Exclusion criteria

• HbA1c > 10%,
• not treated with basal-bolus (insulin glargine / detemir with insulin lispro / aspart),
• aged <18 > 50.

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

13 participants in 1 patient group

Insulin dose

Other group

Description:

Reducing rapid-acting insulin dose (insulin aspart or lispro) after exercise.

Treatment:

Other: Reducing post-exercise rapid-acting insulin (insulin lispro or aspart) dose